BAGANBAZAR GRAPHEXPLORE · ANALYZE · GROW
Theme
LiveDesk
WorldLassonde Industries Inc. Will Hold a Conference Call To Discuss Its Third Quarter 2026 Financial ResultsScienceChimps Steal Less Often From Their Friends, Even When Offered PineappleScienceWhat makes glass good at conducting heat? Sound holds the keyScienceHow to speak whale: AI uses eight to ten click sequences to predict sperm whales' feeding divesScienceFrom 'gentle' and 'graceful' to the 'cane toad of the sky': How Australia turned on the common myna
World/Source-attributed reporting
World DESK

Lassonde Industries Inc. Will Hold a Conference Call To Discuss Its Third Quarter 2026 Financial Results

ROUGEMONT, Quebec, Oct. 23, 2026 (GLOBE NEWSWIRE) — Lassonde Industries Inc. (TSX: LAS.A) (“Lassonde” or the “Corporation”) is pleased to announce that it will host a conference call to discuss its financial results for the third quarter of 2026 on Friday, November 6, 2026. Mr. Vince Timpano, Chief Executive Officer, and Mr. Francis Trudeau, Chief […]

Published Oct 23, 2026 · 9:30 AMOriginal source: Financial Post2 reads
ROUGEMONT, Quebec, Oct. 23, 2026 (GLOBE NEWSWIRE) — Lassonde Industries Inc. (TSX: LAS.A) (“Lassonde” or the “Corporation”) is pleased to announce that it will host a conference call to discuss its financial results for the third quarter of 2026 on Friday, November 6, 2026. Mr. Vince Timpano, Chief Executive Officer, and Mr. Francis Trudeau, Chief […]
ORIGINAL SOURCE

Financial Post

This report is indexed by BAGANBAZAR GRAPH with its original publisher named and linked for readers.

Read at original outlet ↗
RELATED COVERAGE

More from this desk.

BAGANBAZAR GRAPHSource-attributed newsWORLD desk
World

Precede Biosciences Presents ESMO 2026 Data Revealing Biology Associated with Response and Resistance to PSMA-Directed Radioligand Therapy in Advanced Prostate Cancer

Baseline plasma profiling identified three molecular states previously characterized in tissue: androgen receptor (AR)-high/metabolic, stem/epithelial–mesenchymal transition (EMT), and AR-low/proliferative. The AR-high/metabolic group showed the most favorable outcome trends. Analysis of published gene sets corroborated these findings: higher stem-like and WNT signaling activity was associated with shorter time to next treatment, while higher AR signaling and […]

Original sourceFinancial Post